hero section gradient
5 handpicked stocks

Global Income Stocks | Brazil Operations Focus

For Brazilians seeking income and diversification, this theme provides a way to tap into the country’s growth potential with potentially reduced local market risk. This basket is composed of US and EU-listed multinational companies that pay dividends and have significant operations in Brazil.

Author avatar

Han Tan | Market Analyst

Published on October 13

Your Basket's Financial Footprint

Summary of market capitalisation and investor takeaways for the provided basket.

Key Takeaways for Investors:
  • Large-cap dominance tends to reduce volatility, offering more stable returns and closer broad-market tracking.
  • Use as a core portfolio holding rather than a speculative allocation.
  • Expect steady, long-term income and modest capital appreciation rather than short-term explosive gains.
Total Market Cap
  • VALE: $48.39B

  • TEF: $28.74B

  • BUD: $107.24B

  • Other

About This Group of Stocks

1

Our Expert Thinking

This strategy combines the stability of established global corporations with exposure to Brazil's economic growth. By investing in multinational dividend champions that generate significant revenue from Brazil, you can participate in the country's potential whilst benefiting from the financial strength of internationally-listed companies.

2

What You Need to Know

These are large, stable multinational corporations listed on major US and European exchanges that pay regular dividends. They operate across key Brazilian sectors like mining, consumer goods, and telecommunications, offering a way to diversify internationally whilst maintaining connection to local economic growth.

3

Why These Stocks

Each company was selected for its substantial Brazilian operations and consistent dividend payments. These multinational dividend champions provide exposure to essential Brazilian industries through the financial stability of established global firms that consistently reward shareholders with income.

Why You'll Want to Watch These Stocks

💰

Steady Income Stream

These multinational giants consistently pay dividends whilst benefiting from Brazil's economic growth. It's a smart way to earn regular income from globally diversified companies.

🌍

Best of Both Worlds

Get exposure to Brazil's growth potential through the stability of international exchanges. You're investing in local economic success with reduced home market risk.

🏆

Dividend Champions

These are established global firms with proven track records of rewarding shareholders. They operate in essential Brazilian industries and have the financial strength to maintain consistent payouts.

Get the full story on this Basket. Read our detailed article on its risks and potential.

Read Full Insight

Why Invest with Nemo Money?

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Discover More Opportunities

Automotive Semiconductor Gap Explained | Market Shift

Automotive Semiconductor Gap Explained | Market Shift

A major semiconductor supplier's export ban from China is halting vehicle production, creating a potential opening for other chip manufacturers. This theme identifies alternative semiconductor companies poised to fill the critical supply gap for the automotive industry.

Brazil Smart Farming Tech Investment Basket 2025

Brazil Smart Farming Tech Investment Basket 2025

As Brazil solidifies its role as a global agricultural leader, advanced technologies are unlocking new levels of productivity and sustainability for its farms. This basket offers exposure to the US and EU-listed companies providing the essential hardware, software, and data analytics driving this transformation.

Weight-Loss Drug M&A: Valuation Risk Concerns

Weight-Loss Drug M&A: Valuation Risk Concerns

Novo Nordisk's superior bid for Metsera has ignited a bidding war with Pfizer, highlighting the intense M&A activity in the obesity drug market. This theme focuses on other biotech companies with promising weight-loss therapies that could become the next acquisition targets.

Frequently Asked Questions